UPDATED: Pfizer hikes bid for AstraZeneca to $117B, swears off hostile maneuver

John Carroll

has upped its bid for  to £55 a share, or $ 117 billion, hitting the "magic number" that bankers close to these talks have said will force the reluctant U.K. pharma giant to the table. 

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS